The C-terminal tail of CRTH2 is a key molecular determinant that constrains Gα i and downstream signaling cascade activation

Ralf Schröder, Nicole Merten, Jesper Mosolff Mathiesen, Lene Martini, Anamarija Kruljac-Letunic, Friederike Krop, Andree Blaukat, Ye Fang, Elizabeth Tran, Trond Ulven, Christel Drewke, Jennifer Whistler, Leonardo Pardo, Jesús Gomeza, Evi Kostenis

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Prostaglandin D 2 activation of the seven-transmembrane receptor CRTH2 regulates numerous cell functions that are important in inflammatory diseases, such as asthma. Despite its disease implication, no studies to date aimed at identifying receptor domains governing signaling and surface expression of human CRTH2. We tested the hypothesis that CRTH2 may take advantage of its C-tail to silence its own signaling and that this mechanism may explain the poor functional responses observed with CRTH2 in heterologous expression systems. Although the C terminus is a critical determinant for retention of CRTH2 at the plasma membrane, the presence of this domain confers a signaling-compromised conformation onto the receptor. Indeed, a mutant receptor lacking the major portion ofits C-terminal tail displays paradoxically enhanced Gα i and ERK1/2 activation despite enhanced constitutive and agonist-mediated internalization. Enhanced activation of Gα i proteins and downstream signaling cascades is probably due to the inability of the tail-truncated receptor to recruit β-arrestin2 and undergo homologous desensitization. Unexpectedly, CRTH2 is not phosphorylated upon agonist-stimulation, a primary mechanism by which GPCR activity is regulated. Dynamic mass redistribution assays, which allow label-free monitoring of all major G protein pathways in real time, confirm that the C terminus inhibits Gα i signaling of CRTH2 but does not encode G protein specificity determinants. We propose that intrinsic CRTH2 inhibition by its C terminus may represent a rather unappreciated strategy employed by a GPCR to specify the extent of G protein activation and that this mechanism may compensate for the absence of the classical phosphorylation-dependent signal attenuation.

Original languageEnglish (US)
Pages (from-to)1324-1336
Number of pages13
JournalJournal of Biological Chemistry
Volume284
Issue number2
DOIs
StatePublished - Jan 9 2009
Externally publishedYes

Fingerprint

GTP-Binding Proteins
Tail
Chemical activation
Prostaglandins D
Asthma
Phosphorylation
Cell Membrane
Cell membranes
Conformations
Labels
Assays
Display devices
Proteins
Monitoring

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Schröder, R., Merten, N., Mathiesen, J. M., Martini, L., Kruljac-Letunic, A., Krop, F., ... Kostenis, E. (2009). The C-terminal tail of CRTH2 is a key molecular determinant that constrains Gα i and downstream signaling cascade activation. Journal of Biological Chemistry, 284(2), 1324-1336. https://doi.org/10.1074/jbc.M806867200

The C-terminal tail of CRTH2 is a key molecular determinant that constrains Gα i and downstream signaling cascade activation. / Schröder, Ralf; Merten, Nicole; Mathiesen, Jesper Mosolff; Martini, Lene; Kruljac-Letunic, Anamarija; Krop, Friederike; Blaukat, Andree; Fang, Ye; Tran, Elizabeth; Ulven, Trond; Drewke, Christel; Whistler, Jennifer; Pardo, Leonardo; Gomeza, Jesús; Kostenis, Evi.

In: Journal of Biological Chemistry, Vol. 284, No. 2, 09.01.2009, p. 1324-1336.

Research output: Contribution to journalArticle

Schröder, R, Merten, N, Mathiesen, JM, Martini, L, Kruljac-Letunic, A, Krop, F, Blaukat, A, Fang, Y, Tran, E, Ulven, T, Drewke, C, Whistler, J, Pardo, L, Gomeza, J & Kostenis, E 2009, 'The C-terminal tail of CRTH2 is a key molecular determinant that constrains Gα i and downstream signaling cascade activation', Journal of Biological Chemistry, vol. 284, no. 2, pp. 1324-1336. https://doi.org/10.1074/jbc.M806867200
Schröder, Ralf ; Merten, Nicole ; Mathiesen, Jesper Mosolff ; Martini, Lene ; Kruljac-Letunic, Anamarija ; Krop, Friederike ; Blaukat, Andree ; Fang, Ye ; Tran, Elizabeth ; Ulven, Trond ; Drewke, Christel ; Whistler, Jennifer ; Pardo, Leonardo ; Gomeza, Jesús ; Kostenis, Evi. / The C-terminal tail of CRTH2 is a key molecular determinant that constrains Gα i and downstream signaling cascade activation. In: Journal of Biological Chemistry. 2009 ; Vol. 284, No. 2. pp. 1324-1336.
@article{cf78ec1d4b1744e9898e09336dede188,
title = "The C-terminal tail of CRTH2 is a key molecular determinant that constrains Gα i and downstream signaling cascade activation",
abstract = "Prostaglandin D 2 activation of the seven-transmembrane receptor CRTH2 regulates numerous cell functions that are important in inflammatory diseases, such as asthma. Despite its disease implication, no studies to date aimed at identifying receptor domains governing signaling and surface expression of human CRTH2. We tested the hypothesis that CRTH2 may take advantage of its C-tail to silence its own signaling and that this mechanism may explain the poor functional responses observed with CRTH2 in heterologous expression systems. Although the C terminus is a critical determinant for retention of CRTH2 at the plasma membrane, the presence of this domain confers a signaling-compromised conformation onto the receptor. Indeed, a mutant receptor lacking the major portion ofits C-terminal tail displays paradoxically enhanced Gα i and ERK1/2 activation despite enhanced constitutive and agonist-mediated internalization. Enhanced activation of Gα i proteins and downstream signaling cascades is probably due to the inability of the tail-truncated receptor to recruit β-arrestin2 and undergo homologous desensitization. Unexpectedly, CRTH2 is not phosphorylated upon agonist-stimulation, a primary mechanism by which GPCR activity is regulated. Dynamic mass redistribution assays, which allow label-free monitoring of all major G protein pathways in real time, confirm that the C terminus inhibits Gα i signaling of CRTH2 but does not encode G protein specificity determinants. We propose that intrinsic CRTH2 inhibition by its C terminus may represent a rather unappreciated strategy employed by a GPCR to specify the extent of G protein activation and that this mechanism may compensate for the absence of the classical phosphorylation-dependent signal attenuation.",
author = "Ralf Schr{\"o}der and Nicole Merten and Mathiesen, {Jesper Mosolff} and Lene Martini and Anamarija Kruljac-Letunic and Friederike Krop and Andree Blaukat and Ye Fang and Elizabeth Tran and Trond Ulven and Christel Drewke and Jennifer Whistler and Leonardo Pardo and Jes{\'u}s Gomeza and Evi Kostenis",
year = "2009",
month = "1",
day = "9",
doi = "10.1074/jbc.M806867200",
language = "English (US)",
volume = "284",
pages = "1324--1336",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "2",

}

TY - JOUR

T1 - The C-terminal tail of CRTH2 is a key molecular determinant that constrains Gα i and downstream signaling cascade activation

AU - Schröder, Ralf

AU - Merten, Nicole

AU - Mathiesen, Jesper Mosolff

AU - Martini, Lene

AU - Kruljac-Letunic, Anamarija

AU - Krop, Friederike

AU - Blaukat, Andree

AU - Fang, Ye

AU - Tran, Elizabeth

AU - Ulven, Trond

AU - Drewke, Christel

AU - Whistler, Jennifer

AU - Pardo, Leonardo

AU - Gomeza, Jesús

AU - Kostenis, Evi

PY - 2009/1/9

Y1 - 2009/1/9

N2 - Prostaglandin D 2 activation of the seven-transmembrane receptor CRTH2 regulates numerous cell functions that are important in inflammatory diseases, such as asthma. Despite its disease implication, no studies to date aimed at identifying receptor domains governing signaling and surface expression of human CRTH2. We tested the hypothesis that CRTH2 may take advantage of its C-tail to silence its own signaling and that this mechanism may explain the poor functional responses observed with CRTH2 in heterologous expression systems. Although the C terminus is a critical determinant for retention of CRTH2 at the plasma membrane, the presence of this domain confers a signaling-compromised conformation onto the receptor. Indeed, a mutant receptor lacking the major portion ofits C-terminal tail displays paradoxically enhanced Gα i and ERK1/2 activation despite enhanced constitutive and agonist-mediated internalization. Enhanced activation of Gα i proteins and downstream signaling cascades is probably due to the inability of the tail-truncated receptor to recruit β-arrestin2 and undergo homologous desensitization. Unexpectedly, CRTH2 is not phosphorylated upon agonist-stimulation, a primary mechanism by which GPCR activity is regulated. Dynamic mass redistribution assays, which allow label-free monitoring of all major G protein pathways in real time, confirm that the C terminus inhibits Gα i signaling of CRTH2 but does not encode G protein specificity determinants. We propose that intrinsic CRTH2 inhibition by its C terminus may represent a rather unappreciated strategy employed by a GPCR to specify the extent of G protein activation and that this mechanism may compensate for the absence of the classical phosphorylation-dependent signal attenuation.

AB - Prostaglandin D 2 activation of the seven-transmembrane receptor CRTH2 regulates numerous cell functions that are important in inflammatory diseases, such as asthma. Despite its disease implication, no studies to date aimed at identifying receptor domains governing signaling and surface expression of human CRTH2. We tested the hypothesis that CRTH2 may take advantage of its C-tail to silence its own signaling and that this mechanism may explain the poor functional responses observed with CRTH2 in heterologous expression systems. Although the C terminus is a critical determinant for retention of CRTH2 at the plasma membrane, the presence of this domain confers a signaling-compromised conformation onto the receptor. Indeed, a mutant receptor lacking the major portion ofits C-terminal tail displays paradoxically enhanced Gα i and ERK1/2 activation despite enhanced constitutive and agonist-mediated internalization. Enhanced activation of Gα i proteins and downstream signaling cascades is probably due to the inability of the tail-truncated receptor to recruit β-arrestin2 and undergo homologous desensitization. Unexpectedly, CRTH2 is not phosphorylated upon agonist-stimulation, a primary mechanism by which GPCR activity is regulated. Dynamic mass redistribution assays, which allow label-free monitoring of all major G protein pathways in real time, confirm that the C terminus inhibits Gα i signaling of CRTH2 but does not encode G protein specificity determinants. We propose that intrinsic CRTH2 inhibition by its C terminus may represent a rather unappreciated strategy employed by a GPCR to specify the extent of G protein activation and that this mechanism may compensate for the absence of the classical phosphorylation-dependent signal attenuation.

UR - http://www.scopus.com/inward/record.url?scp=59449089513&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=59449089513&partnerID=8YFLogxK

U2 - 10.1074/jbc.M806867200

DO - 10.1074/jbc.M806867200

M3 - Article

C2 - 19010788

AN - SCOPUS:59449089513

VL - 284

SP - 1324

EP - 1336

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 2

ER -